跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 東晟
副教授
,
大腸直腸外科
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0003-2185-0832
電子郵件
rousse11
tmu.edu
tw
h-index
699
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2009
2024
每年研究成果
概覽
指紋
網路
專案
(3)
研究成果
(52)
類似的個人檔案
(7)
指紋
查看啟用 Tung-Cheng Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Colorectal Cancer
83%
Surgery
63%
Colectomy
44%
Colorectal Surgery
32%
Metastatic Carcinoma
27%
Hemorrhoidectomy
26%
Operation Duration
23%
Overall Survival
21%
Open Surgery
19%
Total Mesorectal Excision
18%
Neoplasm
18%
Disease
18%
Colon Cancer
18%
Learning Curve
17%
Rectum Cancer
16%
Incision
16%
Gastrectomy
16%
Bleeding
16%
Surgical Technique
15%
Surgeon
13%
Survival Rate
13%
Disease Free Survival
12%
Hemorrhoid
11%
Appendectomy
11%
Malignant Neoplasm
10%
Elective Surgery
10%
Prognostic Factor
10%
Case-Control Study
10%
Mortality Rate
10%
Laparoscopic Surgery
9%
Anodyne
9%
Surgical Emergency
9%
Colon Intussusception
9%
Hepatectomy
9%
Laparoscopy
9%
Adjuvant Therapy
9%
Cancer Growth
9%
Cohort Analysis
9%
Infection
8%
Medical Record
8%
Postoperative Pain
8%
Cancer Associated Fibroblast
8%
Programmed Death-Ligand 1
8%
Blood Stasis
8%
Liver Metastasis
8%
Enema
8%
Epidermal Growth Factor Receptor
8%
Long Term Survival
8%
Pericyte
8%
Signal Transduction
8%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
100%
Neoplasm
31%
Malignant Neoplasm
31%
Epidermal Growth Factor Receptor
25%
Breast Cancer
16%
Gefitinib
16%
Postoperative Pain
15%
Drug Resistance
15%
Cancer Growth
13%
Hemorrhoid
11%
Postoperative Complication
11%
Tumor Microenvironment
11%
Carcinogenesis
10%
Tumor Growth
9%
Overall Survival
9%
Bleeding
9%
Protein Kinases
9%
Disease
9%
Catenin
8%
Metastasis
8%
Bone Morphogenetic Protein Receptor 1B
8%
Enema
8%
Androstanolone
8%
Pterostilbene
8%
Stomach Cancer
8%
Cohort Study
8%
Destruxin
8%
microRNA
8%
Chronic Kidney Failure
8%
Acute Cholecystitis
8%
Glutamine
8%
Carcinoembryonic Antigen
8%
Bromelain
8%
Gastrointestinal Stromal Tumor
8%
Reactive Oxygen Metabolite
8%
Survival Rate
8%
Analgesic Agent
7%
Chemotherapy
6%
Disease Free Survival
6%
Resveratrol
6%
Fluorouracil
5%
Colorectal Carcinoma
5%
Antroquinonol
5%
Morphine
5%
Folinic Acid
5%
Oxaliplatin
5%
Protein P53
5%
Cancer Staging
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
25%
Signal Transduction
18%
Gefitinib
16%
Epidermal Growth Factor Receptor
16%
Multivariate Analysis
11%
Protein Kinases
11%
Drug Resistance
10%
Integrin
9%
Eicosanoid Receptor
9%
Upregulation
9%
Overall Survival
9%
Antiproliferative Activity
9%
PD-L1
8%
MicroRNA
8%
Cell Migration
8%
Bioluminescence Imaging
8%
Homeobox
8%
Mesenchymal-Epithelial Transition
8%
Fibroblast
8%
Thrombomodulin
8%
Sialylation
8%
Resveratrol
8%
Starch
8%
Cohort Study
8%
Wnt Signaling Pathway
8%
Catenin
8%
Mir-200
8%
Bone Morphogenetic Protein
8%
Cell Proliferation
7%
P53
7%
Cadherin
5%
